199 related articles for article (PubMed ID: 29689350)
41. Hsa_circ_0005986 inhibits carcinogenesis by acting as a miR-129-5p sponge and is used as a novel biomarker for hepatocellular carcinoma.
Fu L; Chen Q; Yao T; Li T; Ying S; Hu Y; Guo J
Oncotarget; 2017 Jul; 8(27):43878-43888. PubMed ID: 28410211
[TBL] [Abstract][Full Text] [Related]
42. Downregulated circular RNA hsa_circ_0001649 regulates proliferation, migration and invasion in cholangiocarcinoma cells.
Xu Y; Yao Y; Zhong X; Leng K; Qin W; Qu L; Cui Y; Jiang X
Biochem Biophys Res Commun; 2018 Feb; 496(2):455-461. PubMed ID: 29337065
[TBL] [Abstract][Full Text] [Related]
43. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
44. The Circular RNA hsa_circ_0001445 Regulates the Proliferation and Migration of Hepatocellular Carcinoma and May Serve as a Diagnostic Biomarker.
Zhang X; Zhou H; Jing W; Luo P; Qiu S; Liu X; Zhu M; Liang C; Yu M; Tu J
Dis Markers; 2018; 2018():3073467. PubMed ID: 29785229
[TBL] [Abstract][Full Text] [Related]
45. Hsa_circ_0014717 is downregulated in colorectal cancer and inhibits tumor growth by promoting p16 expression.
Wang F; Wang J; Cao X; Xu L; Chen L
Biomed Pharmacother; 2018 Feb; 98():775-782. PubMed ID: 29571246
[TBL] [Abstract][Full Text] [Related]
46. Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer.
Sun CC; Li SJ; Zhang F; Pan JY; Wang L; Yang CL; Xi YY; Li de J
Oncotarget; 2016 Apr; 7(16):21510-26. PubMed ID: 26909600
[TBL] [Abstract][Full Text] [Related]
47. Serum exosomal hsa_circ_0069313 has a potential to diagnose more aggressive non-small cell lung cancer.
Chen Y; Lou C; Ma X; Zhou C; Zhao X; Li N; Tian H; Meng X
Clin Biochem; 2022 Apr; 102():56-64. PubMed ID: 35077682
[TBL] [Abstract][Full Text] [Related]
48. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
[TBL] [Abstract][Full Text] [Related]
49. Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells.
Li Z; Zhu W; Xiong L; Yu X; Chen X; Lin Q
Oncotarget; 2016 Sep; 7(38):61366-61377. PubMed ID: 27542260
[TBL] [Abstract][Full Text] [Related]
50. Identification of circular RNAs as a promising new class of diagnostic biomarkers for human breast cancer.
Lü L; Sun J; Shi P; Kong W; Xu K; He B; Zhang S; Wang J
Oncotarget; 2017 Jul; 8(27):44096-44107. PubMed ID: 28484086
[TBL] [Abstract][Full Text] [Related]
51. A novel circular RNA, hsa_circ_0046701, promotes carcinogenesis by increasing the expression of miR-142-3p target ITGB8 in glioma.
Li G; Yang H; Han K; Zhu D; Lun P; Zhao Y
Biochem Biophys Res Commun; 2018 Mar; 498(1):254-261. PubMed ID: 29337055
[TBL] [Abstract][Full Text] [Related]
52. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene.
Li Y; Zhang H; Li Y; Zhao C; Fan Y; Liu J; Li X; Liu H; Chen J
Mol Carcinog; 2018 Jan; 57(1):125-136. PubMed ID: 28940757
[TBL] [Abstract][Full Text] [Related]
53. A novel circular RNA hsa_circ_0020123 exerts oncogenic properties through suppression of miR-144 in non-small cell lung cancer.
Qu D; Yan B; Xin R; Ma T
Am J Cancer Res; 2018; 8(8):1387-1402. PubMed ID: 30210911
[TBL] [Abstract][Full Text] [Related]
54. Circular RNA hsa_circ_0000745 may serve as a diagnostic marker for gastric cancer.
Huang M; He YR; Liang LC; Huang Q; Zhu ZQ
World J Gastroenterol; 2017 Sep; 23(34):6330-6338. PubMed ID: 28974900
[TBL] [Abstract][Full Text] [Related]
55. ZYG11A serves as an oncogene in non-small cell lung cancer and influences CCNE1 expression.
Wang X; Sun Q; Chen C; Yin R; Huang X; Wang X; Shi R; Xu L; Ren B
Oncotarget; 2016 Feb; 7(7):8029-42. PubMed ID: 26771237
[TBL] [Abstract][Full Text] [Related]
56. MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.
Hu H; Xu Z; Li C; Xu C; Lei Z; Zhang HT; Zhao J
Lung Cancer; 2016 Jul; 97():87-94. PubMed ID: 27237033
[TBL] [Abstract][Full Text] [Related]
57. Circular RNA SMARCA5 may serve as a tumor suppressor in non-small cell lung cancer.
Tong S
J Clin Lab Anal; 2020 May; 34(5):e23195. PubMed ID: 31944395
[TBL] [Abstract][Full Text] [Related]
58. Placenta-specific protein 1 promotes cell proliferation and invasion in non-small cell lung cancer.
Yang L; Zha TQ; He X; Chen L; Zhu Q; Wu WB; Nie FQ; Wang Q; Zang CS; Zhang ML; He J; Li W; Jiang W; Lu KH
Oncol Rep; 2018 Jan; 39(1):53-60. PubMed ID: 29138842
[TBL] [Abstract][Full Text] [Related]
59. MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner.
Shang Y; Zang A; Li J; Jia Y; Li X; Zhang L; Huo R; Yang J; Feng J; Ge K; Yang Y; Zhang Y; Jiang J
Biomed Pharmacother; 2016 Oct; 83():1175-1181. PubMed ID: 27551765
[TBL] [Abstract][Full Text] [Related]
60. Adiponectin inhibits migration and invasion by reversing epithelial‑mesenchymal transition in non‑small cell lung carcinoma.
Cui E; Guo H; Shen M; Yu H; Gu D; Mao W; Wang X
Oncol Rep; 2018 Sep; 40(3):1330-1338. PubMed ID: 29956809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
